Skip to content

Clinical trials

Phase 1 Parasomnias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parasomnias Phase: Phase 1 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20073
20081
20121
20131
20171
20181
20191
20221
20231
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University1
Benha University1
Brooke Army Medical Center1
GlaxoSmithKline1
Hans-Peter Landolt1
Massachusetts General Hospital1
National Human Genome Research Institute (NHGRI)1
Neurim Pharmaceuticals Ltd.1
Northwell Health1
Optimi Health Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parasomnias14
Sleep Initiation and Maintenance Disorders2
Smith-Magenis Syndrome2
Angelman Syndrome1
Anxiety Disorders1
Autism Spectrum Disorder1
Chromosome Deletion1
Cognitive Dysfunction1
Developmental Disabilities1
Headache1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.